OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug mavacamten tested for Long-Term safety in HCM patients
Disease control CompletedThis study looked at the long-term safety of the drug mavacamten in adults with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. About 314 people who had already completed earlier studies took part. The goal was to track any side effects over time, not to…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 07:46 UTC
-
New heart drug shows promise for chinese patients with thick heart muscle
Disease control CompletedThis study tested a drug called aficamten in 40 Chinese adults with a heart condition that makes the heart muscle too thick and blocks blood flow. The goal was to see if the drug is safe and helps the heart pump better over time. Participants had already completed a previous stud…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:04 UTC